TRACON Pharmaceuticals Inc
NASDAQ:TCON 3:59:53 PM EDT
Other Pre-Announcement
TRACON Expects Current Cash And Cash Equivalents Will Fund Operations Into 2023
Published: 05/11/2022 20:58 GMT
TRACON Pharmaceuticals Inc (TCON) - Tracon Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Corporate Update.
Tracon Pharmaceuticals Inc - Expects That Its Current Cash and Cash Equivalents Will Fund Operations Into 2023.
Tracon Pharmaceuticals Inc - Qtrly Loss per Share $0.48.
Tracon Pharmaceuticals Inc - Expects That Its Current Cash and Cash Equivalents Will Fund Operations Into 2023.
Tracon Pharmaceuticals Inc - Qtrly Loss per Share $0.48.